March 24 (Reuters) - RHOEN KLINIKUM AG RHKG.DE :
* FOCUSES ON BEST POSSIBLE CARE OF PATIENTS IN CURRENT
CORONA
CRISIS FOLLOWING INCREASE IN REVENUES IN 2019
* FY REVENUE ROSE 5.8 PERCENT TO 1.3 BILLION EUR
* TOTAL DIVIDEND 0.25 EURPER SHARE
* REVENUES ROSE IN 2019 BY 5.8 PERCENT TO EURO 1.3 BILLION
* FY NET CONSOLIDATED PROFIT AT EURO 44.5 MILLION IS LESS
THAN
LAST YEAR
* GUIDANCE FOR 2020: REVENUES IN AMOUNT OF EURO 1.4 BILLION
+/- 5
PERCENT
* FY EBITDA AT EURO 125.3 MILLION ALMOST REACHED LAST YEAR'S
LEVEL
* SHALL PROPOSE TO ANNUAL GENERAL MEETING DISTRIBUTION OF A
DIVIDEND OF EURO 0.25 PER NON-PAR SHARE
* EXPECT 2020 EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION
AND
AMORTISATION (EBITDA) IN RANGE OF EURO 72.5 MILLION TO EURO 82.5
MILLION
* WILL BE BURDENED HERE WITH AN ADDITIONAL LOW TWO-DIGIT
MILLION
AMOUNT IN FINANCIAL YEAR 2020
* FORECAST REFLECTS REGULATORY INTERVENTION: REGULATION FOR
THRESHOLD FOR NURSING STAFF, NURSING STAFF REINFORCEMENT ACT AND
MINIMUM CASELOAD REQUIREMENTS
Source text for Eikon: ID:nEQ864pB3a
Further company coverage: RHKG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))